ProKidney Plans to Use Proceeds for Clinical Trial Costs, R&D, Continued Investment, General Corporate Purposes >PROK
ProKidney Plans to Use Proceeds for Clinical Trial Costs, R&D, Continued Investment, General Corporate Purposes >PROK
ProKidney计划将收益用于临床试验费用、研发、持续投资、一般企业用途>> PROK
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册